Efficacy of low dose oral minoxidil Versus topical minoxidil solution for the treatment of androgenetic alopecia.
Phase 3
Recruiting
- Conditions
- L64.9Androgenic Alopecia.Androgenic alopecia, unspecified
- Registration Number
- IRCT20210823052264N7
- Lead Sponsor
- Combined Military Hospital Quetta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Clinical diagnosis of AGA score 2-5 on Norwood-Hamilton classification.
Age between 18-55 years.
Patients who haven't received topical or systemic treatment for AGA within 3 months prior to the study.
Exclusion Criteria
Those with other causes of hair loss Such as inflammatory or scarring alopecia.any other types of alopecia
History of severe systemic diseases ( renal, cardiovascular and hepatic)
History of some hormonal disorders.
History of hypertension,hypotension or on any antihypertensive therapy
Hypersensitivity to minoxidil.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method